In 2026, CMS announced a GLP-1 payment demonstration and the BALANCE model aimed at expanding access and lowering costs, with published materials referencing beneficiary out-of-pocket costs under $50/month for eligible participants though the actual numbers depend on participation and program eligibility rules that are still being finalized
If intolerable side effects occur during escalation, remain at current dose for an additional 4 weeks before attempting to increase, or drop back to the previous dose
The treatment benefit on the primary composite endpoint was not evident in patients taking SGLT2 inhibitors at baseline, but there were few events in these patients
On the other hand, biofertilizers are substances containing living microorganisms, mainly bacteria, fungi, or algae, that colonize the rhizosphere or plant roots and enhance nutrient availability to plants